These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 34200826)

  • 1. Structures of HIV-1 Neutralizing Antibody 10E8 Delineate the Mechanistic Basis of Its Multi-Peak Behavior on Size-Exclusion Chromatography.
    Do Kwon Y; Wang XE; Bender MF; Yang R; Li Y; McKee K; Rawi R; O'Dell S; Schneck NA; Shaddeau A; Zhang B; Arnold FJ; Connors M; Doria-Rose NA; Kwong PD; Lei QP
    Antibodies (Basel); 2021 Jun; 10(2):. PubMed ID: 34200826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming the Multiple-Monomeric-Peak Profile of Broadly Neutralizing HIV-1 Antibody 10E8 with a Unique Size-Exclusion-Chromatography Method.
    Li Y; Wang XE; Bender MF; Yang R; Cozine TJ; Atallah KM; Arnold F; Cooper JW; Lei QP
    Anal Chem; 2018 Nov; 90(21):12390-12394. PubMed ID: 30346697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental Pathway of the MPER-Directed HIV-1-Neutralizing Antibody 10E8.
    Soto C; Ofek G; Joyce MG; Zhang B; McKee K; Longo NS; Yang Y; Huang J; Parks R; Eudailey J; Lloyd KE; Alam SM; Haynes BF; ; Mullikin JC; Connors M; Mascola JR; Shapiro L; Kwong PD
    PLoS One; 2016; 11(6):e0157409. PubMed ID: 27299673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of the Solubility of HIV-1-Neutralizing Antibody 10E8 through Somatic Variation and Structure-Based Design.
    Kwon YD; Georgiev IS; Ofek G; Zhang B; Asokan M; Bailer RT; Bao A; Caruso W; Chen X; Choe M; Druz A; Ko SY; Louder MK; McKee K; O'Dell S; Pegu A; Rudicell RS; Shi W; Wang K; Yang Y; Alger M; Bender MF; Carlton K; Cooper JW; Blinn J; Eudailey J; Lloyd K; Parks R; Alam SM; Haynes BF; Padte NN; Yu J; Ho DD; Huang J; Connors M; Schwartz RM; Mascola JR; Kwong PD
    J Virol; 2016 Jul; 90(13):5899-5914. PubMed ID: 27053554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Optimization of Broadly Neutralizing HIV-1 Antibody 10E8 by Promotion of Membrane Interactions.
    Rujas E; Leaman DP; Insausti S; Ortigosa-Pascual L; Zhang L; Zwick MB; Nieva JL
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29386285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of proline isomerization on potency and stability of anti-HIV antibody 10E8.
    Guttman M; Padte NN; Huang Y; Yu J; Rocklin GJ; Weitzner BD; Scian M; Ho DD; Lee KK
    Sci Rep; 2020 Aug; 10(1):14313. PubMed ID: 32868832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and Thermodynamic Basis of Epitope Binding by Neutralizing and Nonneutralizing Forms of the Anti-HIV-1 Antibody 4E10.
    Rujas E; Gulzar N; Morante K; Tsumoto K; Scott JK; Nieva JL; Caaveiro JM
    J Virol; 2015 Dec; 89(23):11975-89. PubMed ID: 26378169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid interactions and angle of approach to the HIV-1 viral membrane of broadly neutralizing antibody 10E8: Insights for vaccine and therapeutic design.
    Irimia A; Serra AM; Sarkar A; Jacak R; Kalyuzhniy O; Sok D; Saye-Francisco KL; Schiffner T; Tingle R; Kubitz M; Adachi Y; Stanfield RL; Deller MC; Burton DR; Schief WR; Wilson IA
    PLoS Pathog; 2017 Feb; 13(2):e1006212. PubMed ID: 28225819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 10E8-like neutralizing antibodies against HIV-1 induced using a precisely designed conformational peptide as a vaccine prime.
    Yu Y; Tong P; Li Y; Lu Z; Chen Y
    Sci China Life Sci; 2014 Jan; 57(1):117-27. PubMed ID: 24369352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of diversity in gp41 membrane proximal external region of primary HIV-1 Indian subtype C sequences on interaction with broadly neutralizing antibodies 4E10 and 10E8.
    Sutar J; Padwal V; Sonawani A; Nagar V; Patil P; Kulkarni B; Hingankar N; Deshpande S; Idicula-Thomas S; Jagtap D; Bhattacharya J; Bandivdekar A; Patel V
    Virus Res; 2019 Nov; 273():197763. PubMed ID: 31553924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of proline isomerization on antigen binding and the analytical profile of a trispecific anti-HIV antibody.
    Masiero A; Nelly L; Marianne G; Christophe S; Florian L; Ronan C; Claire B; Cornelia Z; Grégoire B; Eric L; Ludovic L; Dominique B; Sylvie A; Marie G; Francis D; Fabienne S; Cécile C; Isabelle A; Jacques D; Jérôme D; Bruno G; Katarina R; Jean-Michel M; Catherine P
    MAbs; 2020; 12(1):1698128. PubMed ID: 31791173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a novel multi-immunogen vaccine strategy for targeting 4E10/10E8 neutralizing epitopes on HIV-1 gp41 membrane proximal external region.
    Banerjee S; Shi H; Banasik M; Moon H; Lees W; Qin Y; Harley A; Shepherd A; Cho MW
    Virology; 2017 May; 505():113-126. PubMed ID: 28237764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for broad neutralization of HIV-1 through the molecular recognition of 10E8 helical epitope at the membrane interface.
    Rujas E; Caaveiro JM; Partida-Hanon A; Gulzar N; Morante K; Apellániz B; García-Porras M; Bruix M; Tsumoto K; Scott JK; Jiménez MÁ; Nieva JL
    Sci Rep; 2016 Dec; 6():38177. PubMed ID: 27905530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure of the HIV-1 broadly neutralizing antibody 10E8 MPER epitope on the membrane surface by gp41 transmembrane domain scaffolds.
    Oakes V; Torralba J; Rujas E; Nieva JL; Domene C; Apellaniz B
    Biochim Biophys Acta Biomembr; 2018 Jun; 1860(6):1259-1271. PubMed ID: 29477358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An immunogen containing four tandem 10E8 epitope repeats with exposed key residues induces antibodies that neutralize HIV-1 and activates an ADCC reporter gene.
    Sun Z; Zhu Y; Wang Q; Ye L; Dai Y; Su S; Yu F; Ying T; Yang C; Jiang S; Lu L
    Emerg Microbes Infect; 2016 Jun; 5(6):e65. PubMed ID: 27329850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential HIV-1 fusion inhibitors mimicking gp41-specific broadly neutralizing antibody 10E8: In silico discovery and prediction of antiviral potency.
    Andrianov AM; Kashyn IA; Tuzikov AV
    J Bioinform Comput Biol; 2018 Apr; 16(2):1840007. PubMed ID: 29439644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elicitation of HIV-1 neutralizing antibodies by presentation of 4E10 and 10E8 epitopes on Norovirus P particles.
    Yu Y; Fu L; Shi Y; Guan S; Yang L; Gong X; Yin H; He X; Liu D; Kuai Z; Shan Y; Wang S; Kong W
    Immunol Lett; 2015 Dec; 168(2):271-8. PubMed ID: 26455781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigp41 membrane proximal external region antibodies and the art of using the membrane for neutralization.
    Cerutti N; Loredo-Varela JL; Caillat C; Weissenhorn W
    Curr Opin HIV AIDS; 2017 May; 12(3):250-256. PubMed ID: 28422789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulating immunogenic properties of HIV-1 gp41 membrane-proximal external region by destabilizing six-helix bundle structure.
    Banerjee S; Shi H; Habte HH; Qin Y; Cho MW
    Virology; 2016 Mar; 490():17-26. PubMed ID: 26803471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eliciting 10E8-like antibodies by the membrane proximal external region peptide of HIV-1 in guinea pigs.
    Yu Y; Fu L; Gong X; Guan S; He X; Yin H; Kuai Z; Kong W; Shi Y; Shan Y
    Biotechnol Lett; 2017 Mar; 39(3):367-373. PubMed ID: 27943074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.